Cargando…
The Mechanism and Role of N(6)-Methyladenosine (m(6)A) Modification in Atherosclerosis and Atherosclerotic Diseases
N(6)-methyladenosine (m(6)A) modification is a newly discovered regulatory mechanism in eukaryotes. As one of the most common epigenetic mechanisms, m(6)A’s role in the development of atherosclerosis (AS) and atherosclerotic diseases (AD) has also received increasing attention. Herein, we elucidate...
Autores principales: | Tan, Quandan, He, Song, Leng, Xinyi, Zheng, Danni, Mao, Fengkai, Hao, Junli, Chen, Kejie, Jiang, Haisong, Lin, Yapeng, Yang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697759/ https://www.ncbi.nlm.nih.gov/pubmed/36354766 http://dx.doi.org/10.3390/jcdd9110367 |
Ejemplares similares
-
Ticagrelor Resistance in Cardiovascular Disease and Ischemic Stroke
por: He, Song, et al.
Publicado: (2023) -
Roles of N(6)‐methyladenosine (m(6)A) RNA modifications in urological cancers
por: Wang, Xiao, et al.
Publicado: (2020) -
Lower Plasma miR-223 Level Is Associated with Clopidogrel Resistance in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
por: Cheng, Hang, et al.
Publicado: (2023) -
Impact of N6-methyladenosine (m(6)A) modification on immunity
por: Elsabbagh, Raghda A., et al.
Publicado: (2022) -
Structural Insights into N(6)-methyladenosine (m(6)A) Modification in the Transcriptome
por: Huang, Jinbo, et al.
Publicado: (2018)